2m 2m 2m 2m 2m 2m 2m
OLEMA PHARMA (OLMA)
NASDAQ
$11.80-$0.05 (-0.41%)
Price as of Jul 14, 2026 4:09 AM EDT- $1.0BMarket Cap
- 145.34%1-Year Change
- BiotechnologyIndustry
OLEMA PHARMA (OLMA)
$11.80-$0.05 (-0.41%)
OLMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.85 | ||
Change | -$0.06 (-0.50%) | ||
Open | $11.90 | ||
High | $12.02 | ||
Low | $11.45 | ||
Previous Close | $11.91 | ||
Volume | 1,226,625 | ||
30-Day Average Volume | 2,008,534 | ||
1-Week Change | -7.20% | ||
1-Month Change | 20.06% | ||
1-Year Change | 145.34% | ||
3-Year Change | 35.89% | ||
5-Year Change | -53.78% | ||
Fundamentals | |||
Shares Outstanding | 87.3M | ||
Total Assets | $530.6M | ||
Market Cap | $1.0B | ||
Enterprise Value | $990.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$53.1M | ||
Free Cash Flow | -$46.0M | ||
EBIT | -$53.0M | ||
EBITDA | -$52.9M | ||
Net Working Capital | $466.1M | ||
EPS | -$0.52 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -23 | ||
PEG | 7 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue